Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
29,32 USD | +1,35% | -0,27% | -9,23% |
Attività
Numero di dipendenti: 246
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 438 | 100,0 % | 582 | 100,0 % | +32,93% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 438 | 100,0 % | 582 | 100,0 % | +32,93% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Jeffrey Dayno
CEO | Chief Executive Officer | 66 | 01/11/17 |
Director of Finance/CFO | 53 | 29/03/21 | |
David Bradshaw
CTO | Chief Tech/Sci/R&D Officer | 62 | - |
Tricia Glover
CMP | Compliance Officer | - | - |
Luis Sanay
IRC | Investor Relations Contact | - | 01/03/22 |
Cate McCanless
PRN | Corporate Officer/Principal | - | - |
Audrey Murphy
HRO | Human Resources Officer | - | - |
Sharon Goldbach
PRN | Corporate Officer/Principal | - | - |
Ulrich Christian
LAW | General Counsel | - | 01/01/21 |
Andrew Serafin
PRN | Corporate Officer/Principal | 49 | 01/09/17 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Jeffrey Aronin
FOU | Founder | 56 | 25/07/17 |
R. Graf
BRD | Director/Board Member | 59 | 11/11/20 |
Andreas Wicki
BRD | Director/Board Member | 64 | 01/09/17 |
Jack Nielsen
BRD | Director/Board Member | 60 | 01/09/17 |
Gary Sender
BRD | Director/Board Member | 62 | 01/08/20 |
Antonio Gracias
BRD | Director/Board Member | 53 | 01/09/17 |
Director/Board Member | 54 | 05/11 | |
Juan Sabater
BRD | Director/Board Member | 59 | 01/01/17 |
Jeffrey Dayno
CEO | Chief Executive Officer | 66 | 01/11/17 |
Linda Szyper
BRD | Director/Board Member | 58 | 18/11/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 56 791 214 | 33 312 251 ( 58,66 %) | 0 | 58,66 % |
Coordinate società
Harmony Biosciences Holdings, Inc.
630 West Germantown Pike Suite 215
19462, Plymouth Meeting
+
http://www.harmonybiosciences.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-9,23% | 1,67 Mrd | |
+25,83% | 661 Mrd | |
+27,00% | 566 Mrd | |
-6,76% | 352 Mrd | |
+20,34% | 332 Mrd | |
+3,00% | 283 Mrd | |
+13,09% | 231 Mrd | |
+5,46% | 200 Mrd | |
-9,61% | 195 Mrd | |
-6,26% | 145 Mrd |
- Borsa valori
- Azioni
- Azione HRMY
- Società Harmony Biosciences Holdings, Inc.